Want to join the conversation?
Fiberoptic products maker $VIAV reported a wider quarterly loss, hurt by a non-cash goodwill impairment charge of $91.4MM related to its Service Enablement segment. The company reported 4Q16 net loss of $70.9MM, or $0.30 per share, compared with a net loss of $40.1MM, or $0.17 per share a year ago. Net revenue rose slightly to $224.1MM.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?